The epidemiology of hematogenous candidiasis caused by different candida species

Clinical Infectious Diseases

Volumn 24, Issue 6, 1997, Pages 1122-1128

  Abi Said, Dima ^a,b   Anaissie, Elias ^a   Uzun, Omrum ^a   Raad, Issam ^a   Pinzcowski, Helio ^a   Vartivarian, Shahe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADULT; AGED; ARTICLE; CANDIDA; CANDIDIASIS; CLASSIFICATION; FEMALE; FUNGEMIA; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; CANDIDA; CANDIDIASIS; FEMALE; FLUCONAZOLE; FUNGEMIA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0031157777     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513663     Document Type: Article

References (27)

1. Beck-Sagué CM, Jarvis WR, the National Nosocomial Infections Surveillance System. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 1993; 167: 1247-51.
2. Pfaller MA. Infection control: opportunistic fungal infections - the increasing importance of Candida species. Infect Control Hosp Epidemiol 1989; 10:270-3.
3. Wey SB, Mori M, Pfaller MA, Woolson RP, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988; 148:2642-5.
4. Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW. Fluconazole and Candida krusei fungemia [letter]. N Engl J Med 1991; 325:1315.
5. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.
6. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-36.
7. Bodey GP, Anaissie EJ, Edwards JE. Definitions of Candida infections. In: Bodey GP, ed. Candidiasis: pathogenesis, diagnosis, and treatment. New York: Raven Press, 1993:407-8.
8. Anaissie E, Samonis G, Kontoyiannis D, et al. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 1995; 14:134-7.
9. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15:197-210.
10. Norusis MJ. Statistical package for the social sciences. Chicago: SPSS, 1994.
11. Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984; 77(suppl 4D):20-7.
12. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality. Am J Med 1981;71:363-70.
13. Bodey GP. Fungal infections complicating acute leukemia. J Chronic Dis 1966; 19:667-87.
14. Kunová A, Trupl J, Dluholucký S, Galová G, Krčméry V. Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species. Clin Infect Dis 1995; 21:226-7.
15. Selby JV. Case-control evaluations of treatment and program efficacy. Epidemiol Rev 1994; 16:90-101.
16. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 1988; 26:429-32.
17. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-8.
18. Uzun O, Anaissie EJ. Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Blood 1995; 86:2063-72.
19. Martino P, Girmenia C, Venditti M, et al. Candida colonization and systemic infection in neutropenic patients: a retrospective study. Cancer 1989; 64:2030-4.
20. McGinley KJ, Larson EL, Leyden JJ. Composition and density of microflora in the sublingual space of the hand. J Clin Microbiol 1988; 26: 950-3.
21. Weems JJ Jr. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992; 14:756-66.
22. Wingard JR, Merz WG, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979; 91:539-43.
23. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7:646-55.
24. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11:379-90.
25. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15:414-21.
26. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980; 142:503-9.
27. Martino P, Girmenia C, Micozzi A, et al. Fungemia in patients with leukemia. Am J Med Sci 1993; 306:225-32.